Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Cambrex Corp (CBM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,402,445
  • Shares Outstanding, K 33,656
  • Annual Sales, $ 532,090 K
  • Annual Income, $ 92,420 K
  • 60-Month Beta 2.41
  • Price/Sales 2.58
  • Price/Cash Flow 10.46
  • Price/Book 2.08

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 0.36
  • Number of Estimates 1
  • High Estimate 0.36
  • Low Estimate 0.36
  • Prior Year 1.21
  • Growth Rate Est. (year over year) -70.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
39.43 +5.68%
on 04/25/19
47.58 -12.41%
on 05/06/19
+1.40 (+3.48%)
since 04/24/19
3-Month
37.09 +12.35%
on 04/03/19
47.58 -12.41%
on 05/06/19
+1.32 (+3.27%)
since 02/22/19
52-Week
33.80 +23.28%
on 02/14/19
69.43 -39.98%
on 09/28/18
-5.88 (-12.37%)
since 05/24/18

Most Recent Stories

More News
5 Biotech Stocks to Gain From Trade Deal Rally on the Horizon

Trade-war resistant stocks such as biotechs would be the first to benefit from a relief rally.

CELG : 95.24 (-0.41%)
INVA : 14.51 (+0.69%)
BDSI : 4.39 (-0.90%)
UBX : 8.47 (+5.35%)
CBM : 41.67 (+2.06%)
Can Cambrex (CBM) Run Higher on Rising Earnings Estimates?

Cambrex (CBM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

CBM : 41.67 (+2.06%)
Bruker Corp is Among the Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (BRKR , CBM , ILMN , NEO , PKI )

We looked at the Life Sciences Tools & Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength....

ILMN : 312.45 (+1.13%)
BRKR : 42.31 (+0.52%)
CBM : 41.67 (+2.06%)
Cambrex (CBM) Surpasses Q1 Earnings Estimates

Cambrex (CBM) delivered earnings and revenue surprises of 17.65% and -0.75%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

CBM : 41.67 (+2.06%)
Cambrex: 1Q Earnings Snapshot

EAST RUTHERFORD, N.J. (AP) _ Cambrex Corp. (CBM) on Thursday reported first-quarter profit of $10.4 million.

CBM : 41.67 (+2.06%)
Cambrex Reports First Quarter 2019 Financial Results

- Acquired Avista Pharma Solutions, broadening capabilities, enhancing revenue growth and expanding customer base -

CBM : 41.67 (+2.06%)
Shares of Neogenomics Inc Rank the Highest in Terms of Relative Performance in the Life Sciences Tools & Services Industry (NEO , CBM , PACB , TMO , ILMN )

Below are the top five companies in the Life Sciences Tools & Services industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks...

PACB : 6.80 (-1.59%)
NEO : 21.25 (+0.62%)
CBM : 41.67 (+2.06%)
Cambrex to Announce First Quarter 2019 Financial Results on May 2, 2019

Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced that first quarter 2019...

CBM : 41.67 (+2.06%)
Cambrex Completes New Quality Control Laboratory for Generic API Development in Milan

Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced that it had opened a...

CBM : 41.67 (+2.06%)
9.7% Return Seen to Date on SmarTrend Cambrex Corp Call (CBM)

SmarTrend identified a Downtrend for Cambrex Corp (NYSE:CBM) on February 5th, 2019 at $41.78. In approximately 2 months, Cambrex Corp has returned 9.74% as of today's recent price of $37.71.

CBM : 41.67 (+2.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade CBM with:

Business Summary

Cambrex Corporation is an innovative life sciences company with a refreshingly human approach. Driven by passion, their pharmaceutical products, expertise and technologies accelerate customers' small molecule therapeutics into markets across the world. The company offers Active Pharmaceutical Ingredients...

See More

Key Turning Points

2nd Resistance Point 42.23
1st Resistance Point 41.95
Last Price 41.67
1st Support Level 41.27
2nd Support Level 40.87

See More

52-Week High 69.43
Fibonacci 61.8% 55.82
Fibonacci 50% 51.61
Fibonacci 38.2% 47.41
Last Price 41.67
52-Week Low 33.80

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar